Clinical Trial: PASSIvation of Vulnerable Plaque With AZD5718 in AcuTe Coronary syndromE

U.S., Oct. 24 -- ClinicalTrials.gov registry received information related to the study (NCT04601467) titled 'PASSIvation of Vulnerable Plaque With AZD5718 in AcuTe Coronary syndromE' on Sept. 11.

Brief Summary: This is a multi-center study conducted at 13 sites in 3 countries (Singapore, New Zealand, and the United Kingdom). Approximately 360 patients with an acute myocardial infarction (AMI) will be randomized in a ratio of 1:1 ratio to receive AZD5718 125 mg or placebo for 12 months.

Study Type: Interventional

Condition: Acute Coronary Syndrome

Intervention: * Drug: AZD5718

Oral dose of AZD5718 (tablet) once daily for 12 months

* Drug: Placebo

Oral dose of matching placebo (tablet) once daily for 12 months

Recruitment Status: Not ...